duloxetine has been researched along with pf 3246799 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brennan, PE; Brown, AD; Bungay, PJ; Conlon, KM; Corbett, MS; de Oliveira, CA; DePianta, RP; Fish, PV; Heifetz, A; Ho, DK; Jessiman, AS; McMurray, G; Roberts, LR; Root, JA; Shanmugasundaram, V; Shapiro, MJ; Skerten, M; Storer, RI; Westbrook, D; Wheeler, S; Whitlock, GA; Wright, J | 1 |
1 other study(ies) available for duloxetine and pf 3246799
| Article | Year |
|---|---|
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.
Topics: Animals; Azepines; Blood-Brain Barrier; Central Nervous System Agents; CHO Cells; Cricetulus; Dogs; Drug Design; Humans; Madin Darby Canine Kidney Cells; Permeability; Pyrimidines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Urinary Incontinence, Stress | 2014 |